CDMO · Private company · Somerset, NJ, US
Catalent, Inc.
SEC CIK 0001596783
Track this companyFree. Adds Catalent, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials2
- A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)PHASE3 · UNKNOWN · started May 1, 2024ClinicalTrials.gov NCT06383273 · fetched Nov 12, 2026
- Single Ascending Dose Study of MEDI1341 in Healthy VolunteersPHASE1 · COMPLETED · started Oct 17, 2017ClinicalTrials.gov NCT03272165 · fetched Nov 12, 2026